RARE position history
The shares of Ultragenyx Pharmaceutical In (RARE) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 149,634 shares, $3.4M, 1.2% of portfolio, New
- 2026 Q1: 390,879 shares, $8.2M, 3.2% of portfolio, Add +161.2%
- 2026 Q2: 390,879 shares, $13M, 5.0% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|